HR Execs on the Move


 
Cytori Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. We are a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery and other serious, chronic, and life threatening conditions.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.cytori.com
  • 3020 Callan Rd
    San Diego, CA USA 92121
  • Phone: 858.458.0900

Executives

Name Title Contact Details

Similar Companies

Dash Medical Gloves

Dash Medical Gloves is a Franklin, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Flow Sciences Inc

Flow Sciences Inc is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Intermountain Therapy Animals

Intermountain Therapy Animals is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

option one

option one is a Corona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Silk Road Medical

Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The TransCarotid Artery Revascularization (TCAR) Procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE® Transcarotid Neuroprotection and Stent System are the first and only products specifically designed and indicated for TCAR in high surgical risk patients that need carotid intervention.